Ligand Pharmaceuticals Incorporated (PC)
Ticker Symbol: USOTC:LGNZZ
OTC Market Tier: Pink Current
CIK Number: 0000886163
Security Type: Rights
LGNZZ Address: 3911 Sorrento Valley Boulevard
Suite 110
San Diego, California 92121
LGNZZ Country: USA
LGNZZ Phone: (858) 550-7500
LGNZZ Fax #: N/A
Website: http://www.ligand.com
Description: Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized:
Shares Outstanding:
Shares Outstanding Date: N/A
Shares Holder Count: N/A
Shares Holder Date: N/A
Market Capitalization:
Key Executives: Erika Luib - IR
Number of Employees: 550
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 1987
Auditor: N/A
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: N/A
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 1,916
Short Date: 02/28/2019
Closing MMID: 7
BFCMmid: 4
Tier ID: 20
Status: Active


Your Recent History
USOTC
LGNZZ
Ligand Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.